Table of Contents Table of Contents
Previous Page  30 / 138 Next Page
Information
Show Menu
Previous Page 30 / 138 Next Page
Page Background

30

Bibliografia

1. Baptista P, Doria G, Quaresma P, Cavadas M, Neves CS, Gomes I, Eaton P, Perei-

ra E, Franco R (2011). Nanoparticles in Molecular Diagnostics, Progress in Molec-

ular Biology and Translational Science: Nanoparticles in Translational Science and

Medicine, volume 104, chapter 11, p. 427-488,Villaverde Antoni, ed., Academic

Press Co., Elsevier Publishing Services.

2. World Health Organization, WHO (2014). World Malaria Report, Geneva,

Switzerland.

3. Prudêncio M, Rodrigues A, Mota MM (2006). The silent path to thousands of

merozoites: the Plasmodium liver stage. Nat Rev Microbiol 4(11): 849-856.

4. Arez AP, Rosário VE (2008).The Relevance of molecular markers in the analysis

of malaria parasite populations.Transboundary and Emerging Diseases 55, 226-232.

5. Bartoloni A, Zammarchi L (2012). Clinical aspects of uncomplicated and severe

malaria. Mediterr. J. Hematol. Infect. Dis 4(1) e2012026.

6. MoodyA (2002). Rapid diagnostic tests for malaria parasites. Clinical Microbiol-

ogy Reviews 15(1) 66-78.

7. Rosenthal PJ (2012). How do we best diagnose malaria in Africa? Am. J.Trop.

Med. Hyg. 86(2), 192-193.

8. Wilson ML (2012). Malaria rapid diagnostic tests. Medical Microbiology 54,

1637-1641.

9. Murray CK, Bennet JW (2009). Rapid diagnosis of malaria. Interdiscip. Per-

spect. Infect. Dis. 1-7.

10. Chodini PL, Bowers K, Jorgensen P, Barnwell JW, Grady KK, Luchavez J,

Moody AH, Cenizal A, Bell D (2007). The heat stability of Plasmodium lactate

dehydrogenase-based and histidine rich protein 2-based malaria rapid diagnostic

tests.Trans R SocTrop Med Hyg 101(4), 331-337.

11.World Health Organization,WHO (versão 2015). Global Malaria Programme,

Information note on recommended selection criteria for procurement of malaria

rapid diagnostic tests.

12. Peixoto de Almeida M, Pereira E, Baptista P, Gomes I, Figueiredo S, Soares L,

Franco R (2014). Gold Nanoparticles as (Bio)Chemical Sensors, Gold Nanoparticles

in Analytical Chemistry, Comprehensive Analytical Chemistry, volume 66, chapter

13, p. 530-562,Valcárcel Miguel and López-Lorente Ángela, ed., Elsevier Publishing

Services.

13. Baptista P, Pereira E, Eaton P, Miranda A, Gomes I, Quaresma P, Franco R

(2008). Gold nanoparticles for the development of clinical diagnosis methods.Anal

Bioanal Chem 391, 943-950.

14. Lévy R (2006). Peptide-capped gold nanoparticles: towards artificial proteins.

ChemBioChem 7, 1141-1145.

15. Sheehan D (2000). Physical Biochemistry: Principles and Applications, John

Wiley & Sons, Chichester.

16. Lopez-Lorent AI, Simonet BM, Valcarcel M (2011). Electrophoretic methods

for the analysis of nanoparticles.Trac-Trends in Analytical Chemistry 30, 58-71.

17. Parak WJ, Pellegrino T, Micheel CM, Gerion D, Williams SC, Alivisatos AP

(2003). Conformation of oligonucleotides attached to gold nanocrystals probed by

gel electrophoresis. Nano Letters 3(1), 33-36.

18. Guirgis BSS, Sá e Cunha C, Gomes I, Cavadas M, Silva I, Doria G, Blatch GL,

Baptista PV, Pereira E, Azzazy HME, Mota MM, Prudêncio M, Franco R (2012).

Gold nanoparticle-based fluorescence immunoassay for malaria antigen detection.

Anal Bioanal Chem 402: 1019-1027.

19.Yetisen AK, Muhammad SA, Lowe CR (2013). Paper-based microfluidic point-

of-care diagnostic devices 13, 2210-2251

20. Costa MN, Veigas B, Jacob JM, Santos DS, Gomes J, Baptista PV, Martins R,

Inácio J, Fortunato E (2014). A low cost, safe, disposable, rapid and self-sustain-

able paper-based platform for diagnostic testing: lab-on-paper 25(9), 094006,

doi:10.1088/0957-4484/25/9/094006

21. Turkevich J, Stevenson PC, Hillier J (1951). A study of the nucleation and

growth processes in the synthesis of colloidal gold. Discuss. Faraday Soc. 11, 55-75.

22. Kimling J, Maier M, Okenve B, KotaidisV, Ballot H, PlechA (2006). Turkevich

method for gold nanoparticle synthesis revisited. J. Phys. Chem. B 110, 15700-

15707.

23. Haiss W, Thanh NTK, Aveyard J, Ferning DG (2007). Determination of size

and concentration of gold nanoparticles from UV-Vis spectra. Anal Chem 79(11):

4215-4221 doi:10.1021/ac0702084.

24. Ndonwi M, Burlingame OO, Miller AS, Tollefsen DM, Broze GJ, Goldberg

DE (2011). Inhibition of antithrombin by Plasmodium falciparum histidine-rich

protein II. Blood 117(23) 6347-6354.

25. Krohn RI (2001). The colorimetric detection and quantification of to-

tal protein. In: Current protocols in cell biology. John Wiley & Sons, Inc.

doi:10.1002/0471143030.cba03hs15.

26.Wilson K,Walker J (2010). Principles andTechniques of Biochemistry and Mo-

lecular Biology, 7th Ed. Cambridge University Press.

27. Bartczak D, Kanaras AG (2011). Preparation of peptide-functionalized gold

nanoparticles using one Pot EDC/Sulfo-NHS coupling. Langmuir 27, 10119-

10123.

28. Cortez J,Vorobieva E, Gralheira D, Osório I, Soares L,Vale N, Pereira E, Go-

mes P, Franco R (2011). Bionanoconjugates of tyrosinase and peptide-derivatised

gold nanoparticles for biosensing of phenolic compounds. J Nanopart Res 13:

1101-1113.

29.Arruebo M,Valladares M, Fernández-González A (2009).Antibody-conjugated

nanoparticles for biomedical applications. Journal of Nanomaterials 1-24.

30. Rebelo M, Tempera C, Fernandes JF, Grobusch MP, Hänscheid T (2015). As-

sessing anti-malarial drug effects

ex vivo

using the haemozoin detection assay. Mala-

ria Journal 14:140, 1-9. doi:10.1186/s12936-015-0657-8.

Artigo Original